Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000167 · ClinicalTrials.gov registry record · Phase 3
Complications of Age-Related Macular Degeneration Prevention Trial
A Phase 3 study, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- Phase 3
- Development phase
- 1,052
- Enrollment target
NCT00000167 is a Phase 3 study that has completed, run by National Eye Institute (NEI). The registered enrollment target is 1,052 participants.
The verdict
NCT00000167, a Phase 3 study, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,052 participants
- Enrollment target
Study Summary
To determine whether application of low-intensity laser treatment of eyes with drusen in the macula can prevent later complications of age-related macular degeneration and thereby preserve visual function.
Interventions
- PROCEDURE Low-Intensity Laser Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,052 participants |
| Start Date | 1999-05 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000167
The ClinicalTrials.gov registry entry for NCT00000167 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,052 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Low-Intensity Laser Treatment is the first listed.
NCT00000167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000167 about?
NCT00000167 is a clinical study titled "Complications of Age-Related Macular Degeneration Prevention Trial". To determine whether application of low-intensity laser treatment of eyes with drusen in the macula can prevent later complications of age-related macular degeneration and thereby preserve visual function.
What is the current status of trial NCT00000167?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,052 participants. The study started on 1999-05. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00000167?
The interventions under investigation include: Low-Intensity Laser Treatment (PROCEDURE).
Who is sponsoring clinical trial NCT00000167?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.